Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Golestaneh L, Alvarez PJ, Reaven NL et al (2017) All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care 23(10 Suppl):S163–S172
2. Sundström J, Bodegard J, Bollmann A et al (2022) Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study. Lancet Reg Health Eur 20:100438
3. Murray R, Zimmerman T, Agarwal A et al (2021) Kidney-Related Research in the United States: a position statement from the National Kidney Foundation and the American Society of Nephrology. Am J Kidney Dis 78(2):161–167
4. Decker E, Kendrick J (2014) Research in the CKD clinic: highs and lows. Adv Chronic Kidney Dis 21(4):344–348
5. Chatzimanouil MKT, Wilkens L, Anders HJ (2019) Quantity and reporting quality of kidney research. J Am Soc Nephrol 30(1):13–22